Should doctors recommend replacing opioids with cannabis? (JAMA)
The largest ever map of the human Alzheimer’s brain highlighting more than 5,800 distinct proteins is available for any scientist to use. (Communications Biology)
Medicare policies have created huge out-of-pocket costs for multiple sclerosis patients. (Health Affairs)
Cannabis effectively helped manage seizures, tics, depression, restlessness, and rage attacks in children with autism. (Scientific Reports)
Roche and biotech partner AC Immune halted two phase III Alzheimer’s trials for the amyloid-targeting antibody crenezumab after an interim analysis showed the primary endpoint probably would be missed. (Endpoints News)
And while results aren’t expected until at least next year, rival Biogen remains mum about its amyloid-targeted antibody aducanumab. (FierceBiotech)
Are mandatory cognitive impairment screenings needed for federal officials? (JAMA Neurology)
Deep brain stimulation increased dementia risk among Parkinson’s patients with mild cognitive impairment. (Journal of Neural Transmission)
The FDA returned Sunovion’s application for sublingual film formulation of apomorphine to treat Parkinson’s disease OFF periods, requesting more information from the drug company.
And speaking of Parkinson’s, singer Linda Ronstadt talks candidly about how the disease has affected her. (Rolling Stone)
Source: MedicalNewsToday.com
